Meta-Analysis of the Effects of Neuropsychological Interventions on Cognitive Function in Non-Central Nervous System Cancer Survivors

Integrative Cancer Therapies

Volumn 15, Issue 4, 2016, Pages 424-434

  Zeng, Yingchun ^a,b   Cheng, Andy S K ^a   Chan, Chetwyn C H ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

cancer survivors; cognitive impairment; meta analysis; neuropsychological interventions

Indexed keywords

ARTICLE; ATTENTION; CANCER SURVIVOR; CLINICAL EFFECTIVENESS; COGNITION; COGNITIVE DEFECT; COGNITIVE REHABILITATION; COGNITIVE THERAPY; COGNITIVE TRAINING; CONTROLLED CLINICAL TRIAL (TOPIC); EXECUTIVE FUNCTION; FOLLOW UP; HUMAN; LEARNING TEST; META ANALYSIS; NERVOUS SYSTEM TUMOR; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPONSE TIME; SYSTEMATIC REVIEW; WORKING MEMORY; NEOPLASM; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVOR;

COGNITION; COGNITION DISORDERS; HUMANS; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; SURVIVORS;

EID: 84995807080     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735416638737     Document Type: Article

References (34)

1. Siegel RL, Miller KD, Jemal A., Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A., Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65: 87-108.
3. Alvarez J, Meyer FL, Granoff DL, Lundy A., The effect of EEG biofeedback on reducing postcancer cognitive impairment. Integr Cancer Ther. 2013; 12: 475-487.
4. Denlinger CS, Ligibel JA, Are M, et al. Survivorship: cognitive function, version 1.2014: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014; 12: 976-986.
5. Wefel JS, Schagen SB., Chemotherapy related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012; 12: 267-275.
6. Janelsins MC, Kesler SR, Ahles TA, Morrow GR., Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014; 26: 102-113.
7. Treanor C, Donnelly M., Late effects of cancer and cancer treatment-a rapid review. J Community Support Oncol. 2014; 12: 137-148.
8. King S, Green HJ., Psychological intervention for improving cognitive function in cancer survivors: a literature review and randomized controlled trial. Front Oncol. 2015; 5: 72.
9. Cimprich B, Reuter-Lorenz P, Nelson J, et al. Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol. 2010; 32: 324-331.
10. Schuurs A, Green HJ., A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life. Psychooncology. 2013; 22: 1043-1049.
11. Mandelblatt JS, Stern RA, Luta G, et al. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol. 2014; 32: 1909-1918.
12. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA., Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010; 116: 3348-3356.
13. Craig CD, Monk BJ, Farley JH, Chase DM., Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment. Support Care Cancer. 2014; 22: 279-287.
14. Kesler S, Hosseini SMH, Heckler C, et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer. 2013; 13: 299-306.
15. Wefel JS, Kesler SR, Noll KR, Schagen SB., Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015; 65: 123-138.
16. Gehring K, Roukema JA, Sitskoorn MM., Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther. 2012; 12: 255-269.
17. Hofmann W, Schmeichel BJ, Baddeley AD., Executive functions and self-regulation. Trends Cogn Sci. 2012; 16: 174-180.
18. Hines S, Ramis MA, Pike S, Chang AM., The effectiveness of psychosocial interventions for cognitive dysfunction in cancer patients who have received chemotherapy: a systematic review. Worldviews Evid Based Nurs. 2014; 11: 187-193.
19. Gehring K, Sitskoorn MM, Aaronson NK, Taphaorn MJ., Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol. 2008; 7: 548-560.
20. Gehring K, Aaronson NK, Taphoorn MJ, Sitskoorn MM., Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Rev Anticancer Ther. 2010; 10: 1779-1795.
21. Gross-King M, Booth-Jones M, Couluris M., Neurocognitive impairment in children treated for cancer: how do we measure cognitive outcomes? J Pediatric Oncol Nurs. 2008; 25: 227-232.
22. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011.
23. Review Manager (RevMan). 5.3. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
24. Cherrier MM, Anderson K, David D, et al. A randomized trial of cognitive rehabilitation in cancer survivors. Life Sci. 2013; 93: 617-622.
25. Ercoli LM, Petersen L, Hunter AM, et al. Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial. Psychooncology. 2015; 24: 1360-1367.
26. Ferguson RJ, McDonald BC, Rocque MA, et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology. 2012; 21: 176-186.
27. Goedendorp MM, Knoop H, Gielissen MF, Verhagen CA, Bleijenberg G., The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance. J Pain Symptom Manage. 2014; 47: 35-44.
28. McDougall GJ, Becker H, Acee TW, Vaughan PW, Delville CL., Symptom management of affective and cognitive disturbance with a group of cancer survivors. Arch Psychiatr Nurs. 2011; 25: 24-35.
29. Von Ah D, Carpenter JS, Saykin A, et al. Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2012; 135: 799-809.
30. Wefel JS, Vardy J, Ahles T, Schagen SB., International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011; 12: 703-708.
31. Jim HS, Phillips KM, Chait S, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol. 2012; 30: 3578-3587.
32. Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T., A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013; 39: 297-304.
33. Joly F, Giffard B, Rigal O, et al. Impact of cancer and its treatment on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and Update since 2012. J Pain Symptom Manage. 2015; 50: 830-841.
34. McHenry AJ,. Management of chemotherapy induced cognitive impairment. http://www.oncolink.org/resources/article.cfm?id=1057. Accessed December 29, 2015.